Feasibility of the Use of Phosphodiesterase Type 5 Inhibitors in a Pharmacologic Prevention Program for Recurrent PriapismArthur L. Burnett, Biljana Musicki, Hunter C. Champion et al.|The Journal of Sexual Medicine|2006Cited by 144
Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapismArthur L. Burnett, Biljana Musicki, Hunter C. Champion et al.|Urology|2006Cited by 127
Endothelial Nitric Oxide Synthase Keeps Erection Regulatory Function Balance in the PenisTrinity J. Bivalacqua, Arthur L. Burnett, Hunter C. Champion et al.|European Urology|2006Cited by 93
Endothelial Nitric Oxide Synthase Regulation in Female Genital Tract StructuresBiljana Musicki, Arthur L. Burnett, Trinity J. Bivalacqua et al.|The Journal of Sexual Medicine|2008Cited by 76
Establishment of a Transgenic Sickle-Cell Mouse Model to Study the Pathophysiology of PriapismTrinity J. Bivalacqua, Hunter C. Champion, Mark T. Gladwin et al.|The Journal of Sexual Medicine|2009Cited by 76